Research progress on the role of new biomarkers in risk assessment and prognosis prediction of cardiogenic shock
Ai Bowen
Chen Yan
Abstract：Cardiogenic shock(CS)is characterized by rapid progression and high mortality,which requires rapidly identification and management of the high-risk patients.The detection of plasma biomarkers is helpful for early risk identification of CS patients,so as to optimize treatment measures.In recent years,the role of new CS biomarkers in shock progression,disease course monitoring and death risk prediction has attracted clinical attention.These biomarkers include markers related to inflammation,immunity,endothelial function,and markers based on proteomics screening.This article reviews the research progress of several novel biomarkers of CS in shock risk assessment and prognosis prediction.
Keywords：Cardiogenic shockNew biomarkersRisk assessmentPrognostic prediction
Publication Date：2024-10-08
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：4( 1554-1557 )